ERROR 1
ERROR 1
ERROR 2
ERROR 2
ERROR 2
ERROR 2
ERROR 2
Password and Confirm password must match.
If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)
ERROR 2
ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.
The biobased chemical maker Lygos is bringing in the synthetic biology specialist Ginkgo Bioworks to help scale up production of two undisclosed organic acids. Lygos ferments aspartic, glyeric, glycolic, isobutyric, lactic, and malonic acids from sugar. Founder and CEO Eric Steen says the 2-year partnership will shorten the path to market for its products, which he says can replace many petroleum-based materials. The investment comes just a few months after the collapse of Lygos’s planned merger with Flexible Solutions International.
Join the conversation
Contact the reporter
Submit a Letter to the Editor for publication
Engage with us on X